Skip to main content
. 2016 Feb 26;19(3):346–349. doi: 10.4103/1008-682X.172826

Figure 2.

Figure 2

Limit of detection (LOD) test for MED12 mutation in exon 2. MED12 mutation was detectable from the concentration of 10% of mutation-positive phyllodes tumor diluted with nonneoplastic breast tissue. Percentage above each figure denotes the concentration of tumor relative to the nonneoplastic tissue with wild type MED12.